Arkolith/Insider Trading/KYTX/Form 4

Seidenberg Beth C

Director, 10% OwnerKyverna Therapeutics, Inc. (KYTX) · full profile →Form 4 · filed Feb 14, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
6
2 non-derivative · 4 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 12, 2024Conversion(C)3.8M——3.8M
Feb 12, 2024Conversion(C)736K——736K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 12, 2024Conversion(C)4.0M—$00
Feb 12, 2024Conversion(C)8.8M—$00
Feb 12, 2024Conversion(C)4.4M—$00
Feb 12, 2024Conversion(C)3.3M—$00

Transaction Codes

C
Conversion of a derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-015465) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML